ProfileGDS4718 / 223595_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 89% 90% 79% 91% 92% 75% 73% 86% 92% 92% 92% 93% 81% 77% 71% 79% 89% 73% 63% 56% 88% 89% 90% 89% 87% 75% 92% 81% 90% 67% 63% 53% 90% 92% 80% 73% 80% 89% 89% 79% 88% 78% 75% 69% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.0902989
GSM549102patient 115, normal, homogenized [OPG study]9.1844190
GSM549104patient 119, normal, homogenized [OPG study]7.8630279
GSM549108patient 138, normal, homogenized [OPG study]9.2603291
GSM549119patient 077, normal, homogenized [OPG study]9.5129692
GSM549133patient 032, cancer, homogenized [OPG study]7.4442875
GSM549139patient 042, cancer, homogenized [OPG study]7.1511673
GSM549099patient 107, normal, homogenized [OPG study]8.5375486
GSM549109patient 139, normal, homogenized [OPG study]9.6102692
GSM549110patient 046, normal, homogenized [OPG study]9.6077992
GSM549114patient 063, normal, homogenized [OPG study]9.6455592
GSM549122patient 082, normal, homogenized [OPG study]9.7588293
GSM549134patient 033, cancer, homogenized [OPG study]8.0332381
GSM549136patient 036, cancer, homogenized [OPG study]7.5724377
GSM549140patient 044, cancer, homogenized [OPG study]7.0267671
GSM549111patient 047, normal, homogenized [OPG study]7.8251379
GSM549113patient 057, normal, homogenized [OPG study]9.2148489
GSM549132patient 031, cancer, homogenized [OPG study]7.1742973
GSM549137patient 038, cancer, homogenized [OPG study]6.3541563
GSM549142patient 047, cancer, homogenized [OPG study]5.9608956
GSM549100patient 110, normal, homogenized [OPG study]8.9046588
GSM549107patient 135, normal, homogenized [OPG study]9.0860789
GSM549115patient 068, normal, homogenized [OPG study]9.3487490
GSM549116patient 072, normal, homogenized [OPG study]9.1599389
GSM549120patient 078, normal, homogenized [OPG study]8.7232187
GSM549131patient 030, cancer, homogenized [OPG study]7.432975
GSM549118patient 074, normal, homogenized [OPG study]9.6473892
GSM549129patient 027, cancer, homogenized [OPG study]7.9688481
GSM549123patient 088, normal, homogenized [OPG study]9.2386190
GSM549124patient 006, cancer, homogenized [OPG study]6.5922567
GSM549126patient 015, cancer, homogenized [OPG study]6.3514863
GSM549128patient 025, cancer, homogenized [OPG study]5.6525153
GSM549103patient 117, normal, homogenized [OPG study]9.0523490
GSM549117patient 073, normal, homogenized [OPG study]9.821992
GSM549138patient 041, cancer, homogenized [OPG study]7.9542680
GSM549141patient 045, cancer, homogenized [OPG study]7.2463673
GSM549130patient 028, cancer, homogenized [OPG study]7.8691280
GSM549101patient 111, normal, homogenized [OPG study]9.0034889
GSM549105patient 128, normal, homogenized [OPG study]8.9539389
GSM549106patient 134, normal, homogenized [OPG study]7.9060479
GSM549112patient 048, normal, homogenized [OPG study]8.9203188
GSM549125patient 011, cancer, homogenized [OPG study]7.611178
GSM549127patient 024, cancer, homogenized [OPG study]7.4539475
GSM549135patient 035, cancer, homogenized [OPG study]6.8463469